Don W. Cleveland

University Of California San Diego

$43,935,794

Attributed

$59,627,528

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.5M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$59,627,528 · 35

By mechanism

R01$32,435,688 · 6

R37$8,968,233 · 3

R35$7,981,707 · 1

RF1$5,589,247 · 2

RC2$3,354,732 · 1

RC1$998,118 · 1

Top collaborators

Most similar at University Of California San Diego

Same institution · by research overlap

Lawrence S Goldstein$14,729,706

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsMediatingGenesMutationMotor NeuronsAmyotrophic Lateral SclerosisLinkProteinsAffectGeneticPreventNeuronsCentromereInheritedSiteCell CyclePropertyMouse ModelChromosomesMicrotubulesVariantEventMutantAneuploidy

Grant awards (106)

Mechanism of ALS/FTD determined by multimodal single cell spatial transcriptomics$3,081,936

RF1 · FY2025 · NS · contact PI

Mechanism of stathmin-2-dependent axon maintenance, regeneration, and function$3,072,075

R37 · FY2025 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$1,021,694

R35 · FY2025 · GM · contact PI

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies$824,437

R01 · FY2025 · NS

Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias$760,099

R01 · FY2025 · NS · contact PI

TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation$749,922

R01 · FY2025 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$1,021,694

R35 · FY2024 · GM · contact PI

Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$839,174

R01 · FY2024 · NS · contact PI

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies$824,437

R01 · FY2024 · NS

Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias$768,106

R01 · FY2024 · NS · contact PI

TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation$754,738

R01 · FY2024 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$1,021,694

R35 · FY2023 · GM · contact PI

Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$853,797

R01 · FY2023 · NS · contact PI

Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias$773,824

R01 · FY2023 · NS · contact PI

TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation$759,909

R01 · FY2023 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$941,397

R35 · FY2022 · GM · contact PI

Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$797,269

R01 · FY2022 · NS · contact PI

TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation$782,427

R01 · FY2022 · NS · contact PI

Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias$779,544

R01 · FY2022 · NS · contact PI

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies$2,507,311

RF1 · FY2021 · NS

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$858,918

R35 · FY2021 · GM · contact PI

Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$798,489

R01 · FY2021 · NS · contact PI

TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation$759,191

R01 · FY2021 · NS · contact PI

Disease mechanism in ALS and frontotemporal dementia$647,454

R01 · FY2021 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$858,918

R35 · FY2020 · GM · contact PI

Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD$826,652

R01 · FY2020 · NS · contact PI

Disease mechanism in ALS and frontotemporal dementia$647,454

R01 · FY2020 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$858,918

R35 · FY2019 · GM · contact PI

Disease mechanism in ALS and frontotemporal dementia$647,454

R01 · FY2019 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$858,918

R35 · FY2018 · GM · contact PI

Disease mechanism in ALS and frontotemporal dementia$647,454

R01 · FY2018 · NS · contact PI

Disease mechanism in ALS and frontotemporal dementia$661,854

R01 · FY2017 · NS · contact PI

Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis$539,556

R35 · FY2017 · GM · contact PI

Guarding the Genome: Aneuploidy and tumorigenesis$601,980

R01 · FY2016 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$492,551

R01 · FY2016 · NS · contact PI

Mammalian Centromere Assembly$361,764

R01 · FY2016 · GM · contact PI

Microtubule Regulation$650,614

R01 · FY2015 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$492,551

R01 · FY2015 · NS · contact PI

Mammalian Centromere Assembly$361,764

R01 · FY2015 · GM · contact PI

Microtubule Regulation$650,614

R01 · FY2014 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$487,625

R01 · FY2014 · NS · contact PI

Mammalian Centromere Assembly$361,764

R01 · FY2014 · GM · contact PI

Junior Faculty and Postdoctoral Fellows Career Development Workshop$74,999

R13 · FY2014 · GM · contact PI

Microtubule Regulation$585,554

R01 · FY2013 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$475,311

R01 · FY2013 · NS · contact PI

Mammalian Centromere Assembly$337,461

R01 · FY2013 · GM · contact PI

Microtubule Regulation$650,614

R01 · FY2012 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$492,551

R01 · FY2012 · NS · contact PI

Mammalian Centromere Assembly$349,701

R01 · FY2012 · GM · contact PI

Microtubule Regulation$635,178

R01 · FY2011 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$602,973

R37 · FY2011 · NS · contact PI

Mammalian Centromere Assembly$349,701

R01 · FY2011 · GM · contact PI

MUTANT SOD1 ASSOCIATION WITH MITOCHONDRIA$7,411

P41 · FY2011 · RR · contact PI

Delivery of therapeutic genes in motor neuron disease$1,674,836

RC2 · FY2010 · NS

Microtubule Regulation$652,315

R01 · FY2010 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$602,963

R37 · FY2010 · NS · contact PI

ALS therapies and genomics for mutant TDP-43 and TLS/FUS$498,544

RC1 · FY2010 · NS · contact PI

Mammalian Centromere Assembly$353,470

R01 · FY2010 · GM · contact PI

PHOSPHORYLATION OF MAD1 BY TTK$2,425

P41 · FY2010 · RR · contact PI

POST-TRANSLATIONAL MODIFICATION AND INTERACTING PROTEINS OF CENP-E$2,425

P41 · FY2010 · RR · contact PI

CHARACTERIZATION OF THE PLK4 KINASE$2,425

P41 · FY2010 · RR · contact PI

ANALYZING MICROGLIA-DERIVED TOXICITY TO MOTOR NEURONS IN ALS$2,425

P41 · FY2010 · RR · contact PI

Delivery of therapeutic genes in motor neuron disease$1,679,896

RC2 · FY2009 · NS

Microtubule Regulation$611,119

R01 · FY2009 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$591,315

R37 · FY2009 · NS · contact PI

ALS therapies and genomics for mutant TDP-43 and TLS/FUS$499,574

RC1 · FY2009 · NS · contact PI

Mammalian Centromere Assembly$293,801

R01 · FY2009 · GM · contact PI

Microtubule Regulation$162,658

R01 · FY2009 · GM · contact PI

IDENTIFICATION OF ON AND OFF SIGNALING CASCADE OF MITOTIC CHECKPOINT$3,309

P41 · FY2009 · RR · contact PI

IN VIVO ASSEMBLY AND DISASSEMBLY PATHWAYS OF CYTOPLASMIC INTERMEDIATE FILAMENTS$3,309

P41 · FY2009 · RR · contact PI

ANALYZING MICROGLIA-DERIVED TOXICITY TO MOTOR NEURONS IN ALS$3,309

P41 · FY2009 · RR · contact PI

Microtubule Regulation$597,169

R01 · FY2008 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$576,188

R37 · FY2008 · NS · contact PI

Mammalian Centromere Assembly$293,801

R01 · FY2008 · GM · contact PI

ANALYZING MICROGLIA-DERIVED TOXICITY TO MOTOR NEURONS IN ALS$8,075

P41 · FY2008 · RR · contact PI

IN VIVO ASSEMBLY AND DISASSEMBLY PATHWAYS OF CYTOPLASMIC INTERMEDIATE FILAMENTS$8,075

P41 · FY2008 · RR · contact PI

MICROTUBULE REGULATION$593,666

R01 · FY2007 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$576,176

R37 · FY2007 · NS · contact PI

Mammalian Centromere Assembly$293,801

R01 · FY2007 · GM · contact PI

NEUROFILAMENT DEPENDENT STRUCTURING OF AXOPLASM$43,413

P41 · FY2007 · RR · contact PI

IDENTIFICATION OF BINDING PARTNERS FOR THE AMINO TERMINUS OF HUMAN CENP-A$6,226

P41 · FY2007 · RR · contact PI

IDENTIFICATION OF ON AND OFF SIGNALING CASCADE OF MITOTIC CHECKPOINT$6,224

P41 · FY2007 · RR · contact PI

NEUROFILAMENTS, AXONAL GROWTH AND MOTOR NEURON DISEASE$2,171

P41 · FY2007 · RR · contact PI

MICROTUBULE REGULATION$593,692

R01 · FY2006 · GM · contact PI

Neurofilaments, SOD1 and Motor Neuron Diseases$576,101

R37 · FY2006 · NS · contact PI

Mammalian Centromere Assembly$316,037

R01 · FY2006 · GM · contact PI

NEUROFILAMENT DEPENDENT STRUCTURING OF AXOPLASM$36,632

P41 · FY2006 · RR · contact PI

NEUROFILAMENTS, AXONAL GROWTH & MOTOR NEURON DISEASE$30,517

P41 · FY2006 · RR · contact PI

MUTANT SOD1 ASSOCIATION WITH MITOCHONDRIA$2,859

P41 · FY2006 · RR · contact PI

THE ROLE OF LATS (LARGE TUMOR SUPPRESSOR) KINASE IN M-PHASE PROGRESSION$2,859

P41 · FY2006 · RR · contact PI

MICROTUBULE REGULATION$590,374

R01 · FY2005 · GM

Neurofilaments, SOD1 and Motor Neuron Diseases$572,780

R37 · FY2005 · NS

NEUROFILAMENT DEPENDENT STRUCTURING OF AXOPLASM$17,286

P41 · FY2005 · RR

MICROTUBULE REGULATION$581,645

R01 · FY2004 · GM

Neurofilaments, SOD1 and Motor Neuron Diseases$525,154

R01 · FY2004 · NS

Neurofilaments, SOD1 and Motor Neuron Diseases$50,000

R01 · FY2004 · NS

NEUROFILAMENTS, AXONAL GROWTH &MOTOR NEURON DISEASE$33,429

P41 · FY2004 · RR

Neurofilaments, SOD1 and Motor Neuron Diseases$509,861

R01 · FY2003 · NS

MICROTUBULE REGULATION$507,969

R37 · FY2003 · GM

MICROTUBULE REGULATION$496,801

R37 · FY2002 · GM

Neurofilaments, SOD1 and Motor Neuron Diseases$495,006

R01 · FY2002 · NS

MICROTUBULE REGULATION$437,221

R37 · FY2001 · GM

Neurofilaments, SOD1 and Motor Neuron Diseases$354,386

R01 · FY2001 · NS

Neurofilaments, SOD1 and Motor Neuron Diseases$3,923

R01 · FY2001 · NS

MICROTUBULE REGULATION$355,671

R37 · FY2000 · GM

NEUROFILAMENTS, SOD1 AND MOTOR NEURON DISEASE$322,827

R01 · FY2000 · NS